精神分裂症谱系障碍与孤独症谱系障碍社会认知表现比较:系统综述、荟萃分析与荟萃回归
该系统综述与荟萃分析比较了精神分裂症谱系障碍(SSD)与孤独症谱系障碍(ASD)患者在社会认知任务上的表现,纳入36项研究进行定性分析、33项进行定量分析,发现两组在情绪加工、心理理论(ToM)及眼睛阅读测验(RMET)上均无统计学显著差异,但研究间异质性显著且仅少量被调节因素解释。
要点
- SSD与ASD在情绪加工、ToM及RMET表现上均无显著差异。
- 研究间异质性显著,年龄差、发表年份、质量评分及抗精神病药使用解释力有限。
- 纳入研究多为小样本、男性为主,且缺乏跨诊断的临床测量工具。
核心结论
- 平均而言,SSD与ASD个体表现出相似程度的社会认知损害。
- 需要更大样本、共识电池和统一报告测量的跨诊断研究来识别更同质的亚组。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、PsycInfo、Embase和Web of Science从建库至2020年7月26日。
- 纳入36项直接比较SSD与ASD社会认知表现的研究进行定性分析(SSD组n=1212,ASD组n=1109)。
- 33项研究纳入定量分析(SSD组n=1113,ASD组n=1015)。
- 采用随机效应模型合并效应量(Hedges g),并使用改良版Newcastle-Ottawa量表进行质量评估。
- 对年龄差、发表年份、质量评估分数和抗精神病药物使用进行荟萃回归。
主要发现
- 情绪加工测量(k=15;g=0.12[95%CI,-0.07至0.30];P=0.21;I²=51.0%;排除1个离群值)无统计学显著差异。
- 研究间SSD与ASD表现差异具有统计学显著异质性,但潜在调节因素仅能解释很少部分。
- 大多数研究参与者为男性(36项研究中SSD组72%[878/1212],ASD组82%[907/1109]),SSD组年龄(均值[SD]28.4[9.5]岁)大于ASD组(23.3[7.6]岁)。
关键数值与推荐
- 纳入标准:原始研究文章,报告SSD和ASD样本基于表现的社会认知测量,以英文发表,使用ICD-10、DSM-IV或更新诊断标准。
临床怎么用
- 临床评估社会认知损害时,不应仅凭诊断类别区分SSD与ASD,两者损害程度平均相似。
- 需注意现有证据多来自小样本、男性为主的研究,跨诊断临床测量工具缺乏。
局限性
- 纳入研究多为小样本且男性占优势。
- 跨诊断临床测量工具匮乏。
- 研究间异质性显著,且年龄差、发表年份、质量评分和抗精神病药物使用等调节因素解释力有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Schizophrenia spectrum disorders (SSDs) and autism spectrum disorder (ASD) both feature social cognitive deficits; however, these disorders historically have been examined separately using a range of tests and subdomain focus and at different time points in the life span. Moving beyond diagnostic categories and characterizing social cognitive deficits can enhance understanding of shared pathways across these disorders. OBJECTIVE: To investigate how deficits in social cognitive domains diverge or overlap between SSDs and ASD based on the extant literature. DATA SOURCES: Literature searches were conducted in MEDLINE, PsycInfo, Embase, and Web of Science from database inception until July 26, 2020. STUDY SELECTION: Original research articles were selected that reported performance-based measures of social cognition in both SSDs and ASD samples. Selected articles also had to be published in English and use International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, DSM-IV, or more recent diagnostic criteria. DATA EXTRACTION AND SYNTHESIS: This systematic review and meta-analysis was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses and Meta-analysis of Observational Studies in Epidemiology reporting guidelines, including data extraction and quality assessment using a modified version of the Newcastle-Ottawa Scale. Data were pooled using a random-effects model. MAIN OUTCOMES AND MEASURES: Effect sizes were calculated as Hedges g (SSDs vs ASD). The primary outcomes were performance on emotion processing tasks, theory of mind (ToM) tasks, and the Reading the Mind in the Eyes Test (RMET) in SSDs compared with ASD. Meta-regressions were performed for age difference, publication year, quality assessment scores, and antipsychotic medication use. RESULTS: Of the 4175 screened articles, 36 studies directly comparing social cognitive performance in individuals with SSDs vs ASD were included in the qualitative analysis (n = 1212 for SSDs groups and n = 1109 for ASD groups), and 33 studies were included in the quantitative analyses (n = 1113 for SSDs groups and n = 1015 for ASD groups). Most study participants were male (number of studies [k] = 36, 72% [878 of 1212] in SSDs groups and 82% [907 of 1109] in ASD groups), and age (k = 35) was older in SSDs groups (mean [SD], 28.4 [9.5] years) than in ASD groups (mean [SD], 23.3 [7.6] years). Included studies highlighted the prevalence of small, male-predominant samples and a paucity of cross-disorder clinical measures. The meta-analyses revealed no statistically significant differences between SSDs and ASD on emotion processing measures (k = 15; g = 0.12 [95% CI, -0.07 to 0.30]; P = .21; I2 = 51.0%; 1 outlier excluded), ToM measures (k = 17; g = -0.01 [95% CI, -0.21 to 0.19]; P = .92; I2 = 56.5%; 1 outlier excluded), or the RMET (k = 13; g = 0.25 [95% CI, -0.04 to 0.53]; P = .10; I2 = 75.3%). However, SSDs vs ASD performance differences between studies were statistically significantly heterogeneous, which was only minimally explained by potential moderators. CONCLUSIONS AND RELEVANCE: In this analysis, similar levels of social cognitive impairment were present, on average, in individuals with SSDs and ASD. Cross-disorder studies of social cognition, including larger samples, consensus batteries, and consistent reporting of measures, as well as data across multiple levels of analysis, are needed to help identify subgroups within and across disorders that may be more homogeneous in etiology and treatment response.
引用
- Oliver LD, Moxon-Emre I, Lai MC, et al. Social Cognitive Performance in Schizophrenia Spectrum Disorders Compared With Autism Spectrum Disorder: A Systematic Review, Meta-analysis, and Meta-regression. JAMA Psychiatry. 2021. PMID: 33291141. doi:10.1001/jamapsychiatry.2020.3908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。